Coherus Oncology, Inc.CHRSNASDAQ
Loading
Total Assets Over TimeContracting
Percentile Rank54
3Y CAGR-18.7%
5Y CAGR-21.0%
Year-over-Year Change
Total value of everything the company owns
3Y CAGR
-18.7%/yr
vs +48.3%/yr prior
5Y CAGR
-21.0%/yr
Consistent
Acceleration
-67.0pp
Decelerating
Percentile
P54
Within normal range
vs 5Y Ago
0.3x
Contraction
Streak
2 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $258.34M | -42.4% |
| 2024 | $448.53M | -28.8% |
| 2023 | $629.60M | +30.9% |
| 2022 | $480.85M | -29.2% |
| 2021 | $679.33M | -19.3% |
| 2020 | $841.65M | +105.8% |
| 2019 | $408.93M | +311.1% |
| 2018 | $99.47M | -38.8% |
| 2017 | $162.61M | -8.9% |
| 2016 | $178.49M | - |